Healthcare -
Biotechnology - NASDAQ - US
$ 1.135
-12 %
$ 4.72 M
Market Cap
-0.09
P/E
MBRX - TOTAL CURRENT LIABILITIES
Total Current Liabilities MBRX - Moleculin Biotech, Inc.
6.82 M
LAST VALUE
37.17%
2 YEAR CAGR
11.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR